U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C15H12O
Molecular Weight 208.2552
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Dibenzosuberone

SMILES

O=C1C2=C(CCC3=C1C=CC=C3)C=CC=C2

InChI

InChIKey=BMVWCPGVLSILMU-UHFFFAOYSA-N
InChI=1S/C15H12O/c16-15-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)15/h1-8H,9-10H2

HIDE SMILES / InChI

Molecular Formula C15H12O
Molecular Weight 208.2552
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Dibenzosuberone is used for the organic synthesis. Dibenzosuberone derivatives are potent inhibitors of p38 mitogen-activated protein kinase. They may foster a new generation of anti-inflammatory drugs. Dibenzosuberone derivatives are potential tricyclic antidepressants and anti-tumor agents.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Synthesis of novel, potentially biologically active dibenzosuberone derivatives.
2005 Dec 31
2H NMR and X-ray diffraction studies of methyl rotation in crystals of ortho-methyldibenzocycloalkanones.
2005 Jul
Sensitive extractive spectrophotometric methods for the determination of nortriptyline hydrochloride in pharmaceutical formulations.
2007 Dec
Evidence for the involvement of the monoaminergic system in the antidepressant-like action of two 4-amine derivatives of 10,11-dihydro-5H-dibenzo [a,d] cycloheptane in mice evaluated in the tail suspension test.
2008 Feb 15
Design, synthesis, and biological evaluation of novel disubstituted dibenzosuberones as highly potent and selective inhibitors of p38 mitogen activated protein kinase.
2012 Jun 28
Dibenzosuberones as p38 mitogen-activated protein kinase inhibitors with low ATP competitiveness and outstanding whole blood activity.
2013 Jan 10
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:07:51 GMT 2025
Edited
by admin
on Mon Mar 31 18:07:51 GMT 2025
Record UNII
8ETK71TH0H
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AMITRIPTYLINE RELATED COMPOUND A
USP-RS  
Preferred Name English
Dibenzosuberone
Common Name English
NORTRIPTYLINE HYDROCHLORIDE IMPURITY A [EP IMPURITY]
Common Name English
DIBENZOCYCLOHEPTENONE
Systematic Name English
10,11-DIHYDRO-5H-DIBENZO(A,D)(7)ANNULEN-5-ONE
Common Name English
5H-DIBENZO(A,D)CYCLOHEPTEN-5-ONE, 10,11-DIHYDRO-
Systematic Name English
2,3:6,7-DIBENZOSUBERONE
Common Name English
10,11-DIHYDRO-5H-DIBENZO(A,D)CYCLOHEPTAN-5-ONE
Common Name English
NSC-49727
Code English
AMITRIPTYLINE HYDROCHLORIDE IMPURITY A [EP IMPURITY]
Common Name English
AMITRIPTYLINE RELATED COMPOUND A [USP-RS]
Common Name English
DIBENZO(A,D)CYCLOHEPTA(1,4)DIEN-5-ONE
Common Name English
DIBENZOSUBERAN-5-ONE
Common Name English
10,11-DIHYDRODIBENZO(A,D)CYCLOHEPTEN-5-ONE
Systematic Name English
DIBENZO(A,D)CYCLOHEPTADIEN-5-ONE
Common Name English
Code System Code Type Description
PUBCHEM
14589
Created by admin on Mon Mar 31 18:07:51 GMT 2025 , Edited by admin on Mon Mar 31 18:07:51 GMT 2025
PRIMARY
CAS
1210-35-1
Created by admin on Mon Mar 31 18:07:51 GMT 2025 , Edited by admin on Mon Mar 31 18:07:51 GMT 2025
PRIMARY
RS_ITEM_NUM
1029013
Created by admin on Mon Mar 31 18:07:51 GMT 2025 , Edited by admin on Mon Mar 31 18:07:51 GMT 2025
PRIMARY
EPA CompTox
DTXSID4049400
Created by admin on Mon Mar 31 18:07:51 GMT 2025 , Edited by admin on Mon Mar 31 18:07:51 GMT 2025
PRIMARY
ECHA (EC/EINECS)
214-912-3
Created by admin on Mon Mar 31 18:07:51 GMT 2025 , Edited by admin on Mon Mar 31 18:07:51 GMT 2025
PRIMARY
FDA UNII
8ETK71TH0H
Created by admin on Mon Mar 31 18:07:51 GMT 2025 , Edited by admin on Mon Mar 31 18:07:51 GMT 2025
PRIMARY
NSC
49727
Created by admin on Mon Mar 31 18:07:51 GMT 2025 , Edited by admin on Mon Mar 31 18:07:51 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
PARENT -> IMPURITY
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP